Neurological Management of Von Hippel-Lindau Disease
Neurologist 21:73-78, Hodgson, T.S.,et al, 2016
Clinicopathologic Conference, Oligdendroglioma II/IV with IDH1 R132H mutation and codelation of 1p and 19q
NEJM 375:2381-2389, Case 38-206, 2016
Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011
Functional Outcome After Language Mapping for Glioma Resection
NEJM 358:18-27, Sanai,N.,et al, 2008
Ischemic Stroke in Patients With Primary Brain Tumor
Neurol 70:2314-2320, Kreisl,T.N.,et al, 2008
Malignant Gliomas in Adults
NEJM 359:492-507, Wen,P.Y. &Kesari,S., 2008
Expression of p53 and Prognosis in Children With Malignant Gliomas
NEJM 346:420-427, Pollack,I.F.,et al, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 Multicenter Trial of Single-Agent High-Dose Methotrexate for Primary Central Nervous System Lymphoma
Ann Neurol 51:247-252, Herrlinger,U.,et al, 2002
Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002
Effects of Resective Surgery for Left-Sided Intracranial Tumors on Language Function:A Prospective Study
Lancet 351:1014-1018, Whittle,I.R.,et al, 1998
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Primary Brain Tumors:Review of Etiology Diagnosis and Treatment
Am Fam Physician 49:787-797, Newton,H.B., 1994
The Limited Value of Cytoreductive Surgery in Elderly Patients with Malignant Gliomas
Neurosurg 34:62-67, Kelly,P.J.&Hunt,C., 1994